chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10 days after the shot, my blood pressure rose to 198/112 and my pulse went to 161. and i called 911 and went to hospital.  i had a severe headache for 3 days leading up to calling 911. finally on the April 1st, i went to hospital. i had a lump on my right shoulder never there before and i felt like the lump was causing my right side of my face to be numb.  The hospital refused to believe me that i had some blood clot, they downplay the incident and instead gave me a brain CT SACN and brain  MRA which was negative, they kept me for observation overnight and let me go noon the next day.  since i have had follow ups with my regular doctor, a cardiologist and my nephrologist.  I know that reaction was due to medication, either way glad i got the shot.  BUT Since this time, I am retaining water, i know this because my rings do not fit anymore, rings i had for 20 years, never ever once had a hard time to put on or remove. I know my body, thats not the worse of it. i test my blood pressure every day at requesting of my kidney doctor,   since the incudent of my pressure 198/112 my diastolic on average is raised  20 points.  I log this daily.  here are some examples from before the medication  111/67 ,  109/63 ,   129/64 , 105/62 120/81.   now my pressure is totally different for example, 155/88  150/91  157/90 ,  134/88.  nothing else changed in my life, I am exactly the same as before only now i have covid shot..  yesterday i saw the 4th doctor since i am shot up and she gave me a new pill  olmesartan medoxomil,  only on it one day but my diastolic pressure is still much higher than before.  i dont want to die, i dont want a stroke, or a heart attach, i have a lot to live for still.  nobody is helping me, doctors are just throwing pills at me and not treating root cause which i feel strongly to beleive it is from covid shot.
Having pain in arm ever since got Vaccine and she keep going move it; pain is really bad; she cries; missed to sleep; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 63 year-old female patient received bnt162b2 (BNT162B2), administered in arm right (Batch/Lot number: unknown) at the age of 63 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing), notes: Verbatim: Blood pressure high. Concomitant medication(s) included: AMLODIPINE taken for hypertension; LISINOPRIL taken for hypertension. Vaccination history included: Bnt162b2 (First Dose), when the patient was 63 years old, for Covid-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "Having pain in arm ever since got Vaccine and she keep going move it; pain is really bad"; CRYING (non-serious), outcome "unknown", described as "she cries"; INSOMNIA (non-serious), outcome "unknown", described as "missed to sleep".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient called the pharmacy indicating a minor adverse effect of feeling left side of cheekbone numbness upward to under eye.  This effect happened a little after 30 minutes after receiving vaccine around 4:35p.m.  Patient feels as if it is bruised.  No swelling detected at the time of report.  Patient states left eye has always been weaker than the right eye.  Vision is normal.  Patient felt the normal side effect of tiredness.  Patient felt this was an unusual effect that has not been experienced before.  Has been less than 24 hours since incident of report.  Patient will be self monitoring and will report back to us with any changes in effects.  No  other allergic reaction present.
Patient got a fever.  At school on 05/23/2014 the fever went up to 102.1.
Upper respiratory infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a sponsored program. The reporter is the patient.  A 68 year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), administration date 2017 (Batch/Lot number: unknown) as dose number unknown, single for immunisation. Relevant medical history included: "asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Pneumococcal 23 (Approximately 15 years ago), administration date: 2007, for immunization. The following information was reported: UPPER RESPIRATORY TRACT INFECTION (non-serious), outcome "unknown", described as "Upper respiratory infection". Additional information: Approximately 15 years ago patient experienced a fairly serious topical reaction to the pneumococcal 23 vaccination administered to her then immunologist, Who advised her never to repeat Pneumococcal 23. She followed his advice. A little over 5 years ago her general practitioner administered Prevnar 13. She was a 68-year-old woman with a history of asthma, which is well-controlled except when she experience an upper respiratory infection.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Grave's disease; Hyperthyroidism; thyroiditis; Hyperparathyroidism; thyroid nodule; This case was reported by a lawyer and described the occurrence of graves' disease in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced graves' disease (serious criteria GSK medically significant). On an unknown date, the outcome of the graves' disease was unknown.   It was unknown if the reporter considered the graves' disease to be related to Shingrix.  The initial information was received on 10 December 2020 via medical record (case is now medically confirmed). The current condition hypertension and Hypercholesteremia. The patient ingetsted Shingrix 50 MCG Intramuscular on 26 august 2020 and Shingrix 50 MCG/0.5ML Intramuscular on 13 December 2019. The patient had underlying autoimmune disease such as thyroiditis, grave's and Hashimoto thyroiditis, Hyperparathyroidism, primary, Hyperthyroidism, Graves' disease, Thyroid was enlarged. Her labs have been stable. On 24 September 2018 performed us biopsy thyroid fine needle aspiration for grave's disease with multiple thyroid nodules resulted left thyroid dominant nodule biopsy without complication.
PERIPHERAL NEUROPATHY 3/17/2023  &  3/19/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
5mins post vax pt devel a grand mal szs lasting approx 30-40seconds
PATIENT STATED THAT AFTER RECEIVING HER MODERNA VACCINE SHE DEVELOPED WHITE SPOTS ON HER ARMS AND CHEST THAT LOOKED LIKE RINGWORM, SHE CAME AND GOT HER S2ND VACCINE AND THE SPOTS STARTED GETTING BIGGER. STATED THAT SHE WENT TO THE DR AND HAD HER BLOOD AND URINE TAKEN. FOUND BLOOD IN HER URINE, WAS REFERED TO GYNOCOLOGIST AND DERMATOLOGIST.
Armpit swell up, throat was swelling up, asthma attack chest pains, thought I was having a heart attack. Shortness of breath blur vision, diarrhea vomiting chills sweats, plus appetite chest pains body pains body aches.
Pt recv vax on 10/26/98; on 10/27/98 pt exp swelling from thigh to knee w/ redness & itching
04/26/2005 Employee presents with a round circular at site of injection. Appears to be same size as round adhesive band aid placed over site of injection. Administered diphenhydramine 25mg to relieve itching. Event: On 04/20/05 employee received a business travel related injectable vaccine and a circular band aid was placed at the site of vaccination. On 04/24/2005, employee removed the band aid and found a circular shape rash had developed. 04/26/2005: Reported to medical. Skin rash on left upper arm possibly due to sensitivity to adhesive bandaid. Administered OTC medication for relief of itching, no restriction, no lost time.
Pain in the neck and shoulder area; Pain in the neck and shoulder area; Diarrhea five days after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea five days after getting the vaccine), NECK PAIN (Pain in the neck and shoulder area) and ARTHRALGIA (Pain in the neck and shoulder area) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Colonoscopy (Patient have had a problem in the past with a medication administered in a colonoscopy procedure.). Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), IRBESARTAN, PARACETAMOL (TYLENOL), MONTELUKAST SODIUM (SINGULAIR), TAMSULOSIN, GUAIFENESIN (MUCINEX), METFORMIN and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced DIARRHOEA (Diarrhea five days after getting the vaccine). On an unknown date, the patient experienced NECK PAIN (Pain in the neck and shoulder area) and ARTHRALGIA (Pain in the neck and shoulder area). At the time of the report, DIARRHOEA (Diarrhea five days after getting the vaccine), NECK PAIN (Pain in the neck and shoulder area) and ARTHRALGIA (Pain in the neck and shoulder area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No new information; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
diarea,poop; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarea,poop) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarea,poop). At the time of the report, DIARRHOEA (diarea,poop) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Information has been received from a certified medical assistant referring to multiple unspecified patients of unknown age and gender. On unknown dates the patients were administered improperly stored LIQUID PEDVAXHIB (lot # L030872 with expiration date 11-JUN-2018, dose, strength and route unknown). The vaccines were exposed at 8.5 degree Celsius for 15 minutes. There was no previous temperature excursion. No adverse event reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Received vaccines and had 3 episodes of vomiting on the car ride home(around 12:01PM 9/3/2020). Stomach now feeling better.
diagnosed with alpha gal / alpha gal allergy; shivering; fever; Condition aggravated; This case was reported by a pharmacist via sales rep and described the occurrence of alpha-gal allergy in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included alpha-gal allergy.   On 19th August 2020, the patient received Shingrix. On 19th August 2020, less than a day after receiving Shingrix, the patient experienced alpha-gal allergy, shivering, fever and condition aggravated. On an unknown date, the outcome of the alpha-gal allergy, shivering, fever and condition aggravated were unknown.   It was unknown if the reporter considered the alpha-gal allergy, shivering, fever and condition aggravated to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and was diagnosed with alpha gal and was inquiring if her symptoms could be exacerbated due to her allergy.  The patient had shivering as if it were aggressive and patient also had a fever. The pharmacist stated they understand those are listed adverse reactions however, the pharmacist was hoping to get more information if there might be a link in patients with an alpha gal allergy. This case linked with US2020167483 and US2020167477, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020167477:same reporter US-GLAXOSMITHKLINE-US2020167483:same reporter
Patient was given 2 vaccinations- HPV and Meningococcal Conjugate.  Within 15 seconds of immunizations patient passed out and fell to the floor.  She then exhibited seizure-like symptoms before coming to.  After this the nurse called for assistance and the Dr. came in to evaluate the situation.  She was then carefully placed on the table where she was having difficulty responding to questions.  She also exhibited loss of strength in her hands when the Dr. asked her to squeeze her hands.  Patient continued to lethargic and very dizzy.  She experienced tingling in her hands as well.  She was given IV fluids- and this did help- however she continued to be dizzy.  Patient vomited several times during this experience- basically every time she was asked to sit up.  After approximately 2 1/2 hours of being monitored and resting- patient was released.  When she arrived home- she continued to be extremely lethargic and vomited several times on 2 occasions.  She was monitored through out the day and night- and continued with her lethargy.  The second day she still remained dizzy and lethargic.
extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extreme fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced FATIGUE (extreme fatigue). At the time of the report, FATIGUE (extreme fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-083137 (Patient Link).
Developed swelling, redness and pain in right leg.  Symptoms started 10/28/21.  Went to ER on 10/30/21 confirmed 2 DVTs in right leg Currently being treated on Eliquis (anti coagulant) since 10/30/2021.
1/30/2021 23:08 Nursing Note Note Text: Patient refused to use incentive spirometer at bedtime. Writer administered prn Mucinex at 1600 and 2130 for upper chest congestion. 02 at 1 liter per NC during thru the night for comfort. 02 sats at 95%. Writer encouraged fluids at bedside. Patient was compliant in taking a shower earlier this afternoon but refused supper. Patient has been mildly confused to place and time, reoriented easily. Will continue monitor vital signs and encourage incentive spirometer.  1/31/2021 00:15 Nursing Note Note Text: Patient had very large incontinent fowl smelling bloody stools at mid noc. Writer called Nurse supervisor also to assess stool. MD was called new order to send patient to hospital for evaluation. Wife was called and updated, bedhold obtained.
A non-serious spontaneous report of patient received one and one-half doses of FLUMIST was received from a health professional concerning a 12-year-old female. Neither the patient's past medical history nor the concomitant medications were reported. On 18-Nov-2011, the patient received FLUMIST, one side of which came out as stream and ran out of the nose. The nurse gave another half dose in that nostril. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
pt recvd vax 4JAN94 & woke up crying & c/o not being able to see for 30 mins; no medical advise was sought that noc;
We received the following information on 21 OCT 2008: A patient experienced an adverse reaction after vaccination with FLUVIRIN. No more information is available. Addendum: We received additional information via a company member on 15 DEC 2008: A female (no further information) was vaccinated with FLUVIRIN (batch no. unknown) during a flu clinic on 09 OCT 2008. Five minutes after the vaccination (while shopping) both arms of the patient turned red and her blood pressure increased. She was transported to a hospital. No further information was provided.
not feeling well; sleeping more than normal; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (not feeling well) and HYPERSOMNIA (sleeping more than normal) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IMMUNOGLOBULIN HUMAN NORMAL (HIZENTRA) for an unknown indication.    On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 27-Feb-2021, the patient experienced VACCINATION COMPLICATION (not feeling well) and HYPERSOMNIA (sleeping more than normal). At the time of the report, VACCINATION COMPLICATION (not feeling well) and HYPERSOMNIA (sleeping more than normal) outcome was unknown.            Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Non-Significant follow up appended
dx of hypotensive, hyporesponsive disorder occurred 1 hrs p/DTP inject will need to take ped DT until age of adult TD;
From initial information received on 05/15/03 from a nurse regarding an adverse event occurring in the USA, it was reported that a 42 year old female pt received TD ADS ADULT, Lot # U0526AA, administered in the left deltoid on the morning of 05/12/03.  Pt developed headache, malaise, night sweats, nausea and chills within 24 hours. The pt also experienced local redness and swelling at the site of injection.  The pt was seen by a physician.  It was reported that the pt had not recovered from these events at the time of this report.
PATIENT WAS GIVEN 3RD MENINGITIS B SHOT ON 08/14/2018 AS ORDERED BY PHYSICIAN DUE TO NEEDING SURGERY. CLIENT CASE TO PUBLIC HEALTH OFFICE ON 08/16/2018 AND HER LEFT UPPER ARM DOWN TO HER WRIST WAS SWOLLEN, RED, HOT AND SHE STATED IT HURT AND SHE HAD NUMBNESS AND TINGLING THROUGHOUT ENTIRE ARM ONE DAY AFTER VACCINATION.
Insomnia; Injection Site Pain; Fatigue; Muscle Pain; Chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A 55 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 10Dec2021 11:00 (Lot number: FF2589) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3247, Location of injection: Arm Left, Vaccine Administration Time: 02:30 PM, Route of Administration: Intramuscular), administration date: 16Mar2021, when the patient was 54 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Left, Vaccine Administration Time: 01:45 PM, Route of Administration: Intramuscular), administration date: 25Feb2021, when the patient was 54 years old, for COVID-19 immunization.  The following information was reported: INSOMNIA (non-serious) with onset 11Dec2021 05:00, outcome "recovering", described as "Insomnia"; VACCINATION SITE PAIN (non-serious) with onset 11Dec2021 05:00, outcome "recovering", described as "Injection Site Pain"; FATIGUE (non-serious) with onset 11Dec2021 05:00, outcome "recovering", described as "Fatigue"; MYALGIA (non-serious) with onset 11Dec2021 05:00, outcome "recovering", described as "Muscle Pain"; CHILLS (non-serious) with onset 11Dec2021 05:00, outcome "recovering", described as "Chills". Therapeutic measures were taken as a result of insomnia, vaccination site pain, fatigue, myalgia, chills.  Additional information: No other vaccine were received in four weeks. other medications were received in two weeks (unspecified). The patient received treatment with Ibuprofen. No covid prior vaccination and not tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
barely move her arm; generalized arm pain at the injection site; This case was reported by a other health professional via sales rep and described the occurrence of injection site pain in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th August 2019, the patient received Shingrix. On 28th August 2019, immediately after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the patient experienced injected limb mobility decreased. On an unknown date, the outcome of the injection site pain was recovering/resolving and the outcome of the injected limb mobility decreased was unknown.   It was unknown if the reporter considered the injection site pain and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient had generalized arm pain at the injection site starting at the time of vaccination. The patient stated that she can barely move her arm. The patient is also a former practice manager who is acquainted with the field representative. The field representative did not have any additional contact information other than the patient's phone number to follow up with her.
Pt recvd 1st dose of Hep B vax on 20MAY91 18 or 72 hrs p/inject devel severe h/a, nausea, vomiting & t102; 22MAY92 hospitalized w/dx of aseptic meningitis; while hospitalized devel macular rash; MD felt sx consistent w/meningitis;;
Sedation, Myalgia, Fever, extensive fatigue, low grade fever, and myalgia reported Narrative: Employee needed to leave work second to symptoms
Pt administered first Rotavirus vaccine at 12 weeks and 2 days;  automatic warning was not triggered; spoke with mom and informed her; no adverse events noted.
Fever to 104.5 late same day of vaccine. Emesis and persistent fever to 101.0 since (2 days) 8cm area red, indurated skin left thigh IM site.
I can feel a lump underneath my left armpit that results in sustained or sharp pain (when active). The lump is starting to gradually decrease in size
Presented to health dept with redness and edema (Lt) arm at Varicella vaccine injection site. States noticed "redness and swelling in the evening of 5-17-13." Started taking BENADRYL. Today throat" itchy and feels tight" referral to ER for evaluation Hx of seasonal allergies. No acute resp. distress.
Mom states pt was weak & drowsy all day; around 6PM pt began shaking, fingernails & lips turned blue; had difficulty breathing was disoriented; also vomited t100 R; Seen in ER given DPH & advised APAP t105 R during noc; MD advised no/pertus
Sore arm at injection site, fatigue, weakness, headache at the back of head, chills that lasted about 12 hours.
Her shoulder is sore but not swollen during palpation and she didn't lose her strength and/or sensibility.